www.standoutstocks.com: Stocks That Stand Out For Sept. 17th, 2009 Are BELM, NYMH, PVCT, CMGR, IDOI, IDTA

Posted on: Thu, 17 Sep 2009 05:14:00 EDT


Symbols: PVCT, BELM, IDTA, IDOI, IDOIE, NYMH, CMGR
Sep 17, 2009 (M2 PRESSWIRE via COMTEX) --
PVCT | Quote | Chart | News | PowerRating -- www.StandoutStocks.com: Stocks That Standout For Sept. 17th, 2009 are Bell Microproducts Inc. (Pink Sheets: BELM | Quote | Chart | News | PowerRating), NYMET Holdings Inc. (PINKSHEETS: NYMH | Quote | Chart | News | PowerRating), Provectus Pharmaceuticals, Inc. (OTCBB: PVCT), Camelot Entertainment Group, Inc. (OTCBB: CMGR | Quote | Chart | News | PowerRating), IDO Security, Inc. (OTCBB: IDOI | Quote | Chart | News | PowerRating), IDenta Corp. (Other OTC: IDTA | Quote | Chart | News | PowerRating)

Visit Us On Twitter and Facebook: http://twitter.com/StandoutStocks http://www.facebook.com/people/Standout-Stocks/547603354 Sign-up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at HYPERLINK "http://www.Standoutstocks.com/" www.Standoutstocks.com __________________________________________________

Pablo Suarez Named President, Bell Micro Latin America

SAN JOSE, Calif., Sep 16, 2009 -- Bell Microproducts Inc. (Pink Sheets: BELM), one of the world's largest value-added distributors of storage and computing technology, today announced the appointment of Pablo Suarez to the position of president, Latin America. In his new position, Suarez will oversee all aspects of business operations in Latin America, reporting directly to Graeme Watt, president of worldwide distribution for Bell Micro.

For the past 15 years, Suarez has held several senior management roles with Ingram Micro, including posts in Europe and the United States. Most recently, Suarez served as vice president and managing director for Ingram Micro's UK operations. Prior to this position, Suarez was managing director for Ingram Micro's Miami export group in Miami, Florida, and Ingram's sales operation in Peru. During his tenure, Suarez contributed to making these operations profitable and stable under challenging market conditions. In addition, Suarez previously ran Ingram Micro's operations in Argentina, and managed purchasing at Ingram's corporate headquarters in Southern California.

"Pablo is a key addition to the company as a whole, and particularly to our operations in Latin America," noted Watt. "We will rely upon his vast experience and knowledge in the IT distribution arena to continue to expand Bell Micro's presence in the region, and to serve our diverse customer base in Latin and Central America." Suarez holds a post graduate degree in Business Management from Austral University, Argentina, a bachelor's degree in Economy from Belgrano University, Argentina, and an Engineering degree from Catholic University, Argentina. He attended the prestigious Global CEO program from the IESE, Business School, University of Navarra, Spain.

About Bell Microproducts Inc.

Bell Microproducts (Pink Sheets:BELM) is an international, value-added distributor of a wide range of high-tech products, solutions and services including, storage systems, servers, software, computer components, and peripherals, as well as maintenance and professional services. An industry-recognized specialist in storage products, the company is one of the world's largest storage-centric value-added distributors.

Bell Microproducts is uniquely qualified with deep technical and application expertise to service a broad range of information technology needs. From design to deployment, its products are available at any level of integration, from components to subsystem assemblies and fully-integrated, tested and certified system solutions. More information can be found in the company's SEC filings, or by visiting the Bell Microproducts web site at www.bellmicro.com.

NYMET Holdings Inc. (NYMH) Announces Purchase Contract With Hong Kong Based Scrap Dealer Coppola Asia Limited

NEW YORK, NY, Sep 16, 2009 -- NYMET Holdings Inc. (PINKSHEETS: NYMH | Quote | Chart | News | PowerRating) (www.nymetusa.com), an innovative metals and mining company headquartered in Port Jefferson, N.Y., announced that they have entered into a Purchase Contract for ferrous scrap metal with Coppola Asia Limited, a scrap dealer based in Hong Kong with major distribution throughout the Pacific Rim.

Mr. Robert Edwards, Executive Account Representative for NYMET Holdings, stated that the Purchase Contract calls for the sale of 1,000 metric tons of HMS 1 & 2 heavy melting scrap steel material. The material is expected to be delivered to Coppola Asia Limited over the next several weeks. This relationship will help develop NYMET's entry into the Hong Kong market. NYMET's management has concluded the logistics and organized the necessary requirements to begin loading and shipping the contracted material later this week. Coppola will have the ability to buy more material once this initial sale is completed. The total 1,000 metric tons of material will commence delivery this week and represents only a fraction of the overall potential the two companies have together.

About Purchaser:

Coppola Asia Limited (HK), established in 2007, is located in central Hong Kong. Coppola specializes in the importing of steel scrap. Coppola has stable suppliers in North and South America, as well as Europe, and sells their products to steel mills in Hong Kong, Taiwan, Vietnam, and China. Further, they have both yard and dock unloading facilities in Hong Kong and China.

Edward R. Gulmi, Senior Vice President of NYMH, stated: "This initial Purchase Contract is a significant achievement for the Company. This transaction allows NYMET to expand its customer base within the Asia markets and we and anticipate additional Purchase Contracts from new customers throughout the upcoming year." DISCLAIMER: CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS The results described herein cannot be guaranteed. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this news release other than statements of historical fact are "forward-looking statements" that are based on current expectations and assumptions. These expectations and assumptions are subject to risks and uncertainty, which could affect NYMET Holdings Inc.'s future. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the statements, including, but not limited to, the following: the ability of NYMET Holdings Inc. to provide for its obligations, to provide working capital needs from operating revenues, to obtain additional financing needed for any future acquisitions, to meet competitive challenges and technological changes, and other risks. NYMET Holdings Inc. undertakes no duty to update any forward-looking statement(s) and/or to confirm the statement(s) to actual results or changes in NYMET Holdings Inc.'s expectations.

Provectus Pharmaceuticals Will Present at the Maxim Group Growth Conference on September 29, 2009

KNOXVILLE, Tenn., Sep 16, 2009 -- Provectus Pharmaceuticals, Inc. (OTCBB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, will present at the Maxim Group Growth Conference on September 29, 2009 at 9:00 a.m. Eastern Time. The conference will be held at the Grand Hyatt Hotel in New York City.

Tim Scott, President of Provectus, will be delivering the presentation. A live webcast of the presentation will be available at the following link: http://www.wsw.com/webcast/maxim2/pvct.ob/ and will be available for 90 days.

About Provectus Pharmaceuticals, Inc. (www.pvct.com)

Provectus Pharmaceuticals specializes in developing oncology and dermatology therapies. Its novel oncology drugs are designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing systemic side effects. Its oncology focus is on melanoma, breast cancer and liver metastases. The Company has received orphan drug designation from the FDA for its melanoma indication. Its dermatological drugs also target abnormal or diseased cells, with the current focus on psoriasis and atopic dermatitis. Provectus has recently completed enrollment in two of its Phase 2 trials -- PV-10 as a therapy for metastatic melanoma, and PH-10 as a topical treatment for atopic dermatitis. It is currently conducting a Phase 2 clinical trial for PH-10 as a topical treatment for psoriasis. Information about these and the Company's other clinical trials can be found at the NIH registry, www.clinicaltrials.gov. For additional information about Provectus please visit the Company's website at www.pvct.com or contact Porter, LeVay & Rose, Inc.

FORWARD-LOOKING STATEMENTS: The forward-looking statements contained herein are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. The company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date thereof.

Camelot Opens Universal City Office for Camelot Distribution Group

IRVINE, CA, Sept 16, 2009 -- Camelot Entertainment Group, Inc. (OTC BB: CMGR | Quote | Chart | News | PowerRating) ("Camelot") announced today that Camelot Distribution Group has opened its new office in Universal City, California. Located at NBC Universal Tower, 10 Universal City Plaza, 20th Floor, Universal City, CA 91608, the new office will serve as the headquarters for Camelot Distribution Group, which handles domestic and international distribution for Camelot. The contact numbers are (818) 308-8858 (phone) and (818) 308-8848 (fax).

The Company recently announced the hiring of Jamie Thompson as President of Camelot Distribution Group.

About Camelot Entertainment Group, Inc.:

Camelot Entertainment Group, Inc. is a US publicly traded company (symbol "CMGR") with three major divisions: Camelot Film Group, Camelot Studio Group and Camelot Production Services Group. Camelot is building a different kind of motion picture studio infrastructure by redefining the development, financing, production, and distribution process. For information about Camelot Entertainment Group, Inc., please visit the Company's web site at www.camelotfilms.com.

NOTES ABOUT FORWARD-LOOKING STATEMENTS Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company's Securities and Exchange Commission reports and filings.

Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward looking statements because they involve unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which they are made.

IDO Security Announces R&D Joint Venture With Emisens of Germany to Develop Explosive Substance Detection Capabilities for the MagShoe

TEL AVIV, ISRAEL, Sep 16, 2009 -- IDO Security, Inc. (OTCBB: IDOI | Quote | Chart | News | PowerRating) (www.idosecurityinc.com), developer of the innovative MagShoe(TM) "shoes-on" weapons metal detection system, today announced that the company has signed an Agreement for Cooperation and Joint Venture Research and Development with German firm Emisens GmbH (www.emisens.com). Emisens GmbH is a spin off from the world renowned Juelich Research Center (www.fz-juelich.de) of Germany.

"IDO Security wishes to further complement and expand the proven metal detection capabilities of the MagShoe(TM) line with the addition of the proposed explosive detection capabilities developed by Emisens. This agreement is based on the accumulated and proven experience of IDO in the metal detection marketplace as well as the proven electromagnetic identification and explosive sensing technologies researched for and developed by Emisens. Furthermore, the agreement will contribute to IDO Security's ongoing effort to increase the level of security attainable by the MagShoe(TM)," stated IDO President, Michael Goldberg.

Mr. Goldberg further stated, "We feel privileged to have the opportunity to attempt to develop what would be a total security solution for both metal and liquid security threats with such a first rate team of scientists and engineers that Emisens will bring to the equation." Emisens CEO, Dr. Norber Klein, added, "It is a privilege for Emisens to collaborate with IDO. We see great opportunities to explore exciting new applications of our sensor technology in combination with the scientific staff and advanced metal detection technology of IDO to create a product that will significantly increase the current level of security available today." Click here to view social media version of this release.

Click here to visit the IDO Security social media newsroom.

About IDO Security

Headquartered in New York with a subsidiary in Israel, IDO Security designs, develops and markets the patented, UL-certified MagShoe(TM) weapons metal detection system. MagShoe(TM) fills a critical void in today's metal detectors by extending screening to the lower body and feet. MagShoe's(TM) unique "shoes-on" design maximizes security, thoroughness and accuracy while eliminating the need to remove shoes for increased convenience and safety. Ideal for security and loss prevention at virtually any facility, MagShoe(TM) is currently in use at international airports, cruise lines, government agencies, prisons and more.

About Emisens

Emisens GmbH (www.emisens.com) was founded in 2007 as an R&D oriented spin-off company from Juelich Research Center (www.fz-juelich.de), one of the largest and most prestigious research centers in Europe. Its scientific foundation is the electromagnetic sensor research in Juelich, which has enjoyed an international reputation for more than ten years. Based in Juelich, Germany, Emisens deals specifically with the research and development, manufacturing, marketing and selling of Systems for Electromagnetic Identification and Sensing of explosive substances. EMISENS systems enhance security for luggage and passenger control in airports. Extremely short time for analysis and easy handling enables the integration in existing checkpoints. Furthermore, Emisens sensor systems enable new challenges for process control, food inspection, and medical diagnostics based in Juelich, Germany.

Forward-Looking Statements: This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry, and that reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward-looking statements are predictions based upon our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed as a result of a number of factors, including but no limited to, the sufficiency of existing capital resources, uncertainties related to the development of IDO's business plan, the ability to secure additional sources of financing, general economic conditions, the availability of competing products and the ultimate market acceptance of our products changes in technology, legislative or regulatory changes that affect us and the risks and uncertainties discussed under the heading "RISK FACTORS" in Item 1A of IDO's Annual Report on Form 10-K for the year ended December 31, 2008, and in our other filings with the Securities and Exchange Commission. We undertake no obligation to revise or update any forward-looking statement for any reason.

International Drug & Explosives Detection Firm IDenta Corp. To Present at Meeting With Officials of the United Nations Office on Drugs and Crime (UNODC)

JERUSALEM, Sept 16, 2009 -- IDenta Corp. (Other OTC: IDTA | Quote | Chart | News | PowerRating) CEO Yaacov Shoham reported today that company officials have been invited to present IDenta drug detectors to officials of the United Nations Office on Drugs and Crime (UNODC). UNODC offices are located in Vienna - Austria.

IDenta management also expects to present the IDenta precursors and the IDenta Alert explosive detectors.

At the meeting will be between 6-10 participants from UNODC , including the head of the office.

Mr. Shoham stated, "It was a quickly organized meeting and will be held next week, Thursday September 24, 2009. The meeting was organized by our local rep in Austria".

Mr. Shoham further stated, "Regarding the UN, it is a very important meeting, no longer than two months ago we started our connection with the UNODC and we are already able to give them a seminar. We are very excited to be able to show the officials of UNODC that our detectors are unequalled in the industry." Meetings with two other Austrian agencies have been scheduled during the business trip next week.

ABOUT IDENTA

Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.

Information concerning IDenta's entire product line may be found at www.IDenta.biz DISCLAIMER Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

About Standoutstocks.com

www.Standoutstocks.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies.

www.Standoutstocks.com email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Standout StocksReport home page at http://www.Standoutstocks.com and select the "join now" button.

Join us at http://www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market.

Disclaimer: Verify all claims and do your own due diligence. Standoutstocks.com profiles are not a solicitation or recommendation to buy, sell or hold securities. Standoutstocks.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Standoutstocks.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Standoutstocks.com is owned and operated by Standoutstocks.com. Neither Standoutstocks.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Standoutstocks.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Standoutstocks.com statements and opinions and such statements and opinions cannot be considered independent. Standoutstocks.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Standoutstocks.com services are often paid for using free-trading shares. Standoutstocks.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

Visit us for a full Disclaimer at: http://www.standoutstocks.com/disclaimer.aspx CONTACT: Jason A. Hilton, Standout Stocks Tel: +1 585 729 8809 e-mail: Jason@Newmediaadvisorsllc.com e-mail: mailto:info@standoutstocks.com

CONTACT: Jason A. Hilton, Standout Stocks
Tel: +1 585 729 8809
e-mail: Jason@Newmediaadvisorsllc.com
e-mail: mailto:info@standoutstocks.com
WWW: http://www.standoutstocks.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on (PVCT) PVCT. (PVCT) has Short Term PowerRatings at TradingMarkets. Details on (PVCT) Short Term PowerRatings is available at This Link.

For full details on (BELM) BELM. (BELM) has Short Term PowerRatings at TradingMarkets. Details on (BELM) Short Term PowerRatings is available at This Link.

For full details on (IDTA) IDTA. (IDTA) has Short Term PowerRatings at TradingMarkets. Details on (IDTA) Short Term PowerRatings is available at This Link.

For full details on (IDOI) IDOI. (IDOI) has Short Term PowerRatings at TradingMarkets. Details on (IDOI) Short Term PowerRatings is available at This Link.

For full details on (IDOIE) IDOIE. (IDOIE) has Short Term PowerRatings at TradingMarkets. Details on (IDOIE) Short Term PowerRatings is available at This Link.

For full details on (NYMH) NYMH. (NYMH) has Short Term PowerRatings at TradingMarkets. Details on (NYMH) Short Term PowerRatings is available at This Link.

For full details on (CMGR) CMGR. (CMGR) has Short Term PowerRatings at TradingMarkets. Details on (CMGR) Short Term PowerRatings is available at This Link.